Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

Search research articles

相关实验视频

Updated: Jul 5, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

对于组织特异性的TRIM.

Marcus D Hartmann^1,2

¹Department of Protein Evolution, Max Planck Institute for Biology Tübingen, 72076 Tübingen, Germany.

ACS medicinal chemistry letters

|January 17, 2024

概括

此摘要是机器生成的。

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Writing the CRBN degron.

Nature chemical biology·2025

Same author

A Facile Protocol for C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Bond Formation Reactions Toward Functionalized E3 Ligase Ligands.

ChemMedChem·2025

Same author

DNA Wrapping by a tetrameric bacterial histone.

Nature communications·2025

Same author

Native metabolomics identifies pteridines as CutA ligands and modulators of copper binding.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

Functional Relevance of CASP16 Nucleic Acid Predictions as Evaluated by Structure Providers.

Proteins·2025

Same author

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.

Journal of medicinal chemistry·2025

Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026

Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026

Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026

Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026

Same journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026

Same journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026

查看所有相关文章

有针对性的蛋白质降解旨在进行组织特异性控制,这是当前广泛表达的E3链酶所面临的挑战. TRIM58酶对开发组织特异性蛋白质溶解向奇默体 (PROTACs) 和分子粘剂具有前景.

科学领域:

分子生物学分子生物学
生物化学生物化学
药物发现药物发现药物发现

背景情况:

组织特异性蛋白质操纵是有针对性的蛋白质降解的关键目标.
目前在向蛋白质降解中使用的E3泛素酶的表达范围很广,限制了组织的特异性.
这种广泛的表达方式阻碍了开发精确的治疗策略.

研究的目的:

探索TRIM58酶在实现组织特异性蛋白质降解方面的潜力.
评估TRIM58作为开发下一代向蛋白质降解剂的工具.

主要方法:

研究TRIM58 E3无素酶的表达模式和活性.
评估在向蛋白质降解策略中使用TRIM58的可行性.
分析TRIM58中介组织特异性蛋白质淘汰的潜力.

主要成果:

TRIM58酶为实现组织特异性蛋白质降解提供了一个潜在的途径.
它的独特特性可以克服与无处不在表达的酶相关的局限性.

结论:

释放TRIM58的潜力可能是针对组织特异性蛋白质溶解向金马 (PROTACs) 和分子降解剂的重大进步.

更多相关视频

Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea

Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea

Published on: September 14, 2012

Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting

Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting

Published on: December 8, 2021

相关实验视频

Last Updated: Jul 5, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea

Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea

Published on: September 14, 2012

Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting

Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting

Published on: December 8, 2021

TRIM58为开发更精确,更有效的蛋白质降解疗法提供了一个有希望的目标.